5651 - 5675 of 6451 Results
Title
Year
- Gender disparities in deep brain stimulation surgery for Parkinson disease and essential tremor2023OPENTitle: Gender disparities in deep brain stimulation surgery for Parkinson disease and essential tremorJournal Name: Deep Brain StimulationPublisher: Elsevier BVVol: 1Issue #:Start Page: 26End Page: 33Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jdbs.2023.04.001Best OA location URL: https://doi.org/10.1016/j.jdbs.2023.04.001Citation Count: 14
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substratesJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 228Issue #: 3-4Start Page: 845End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00429-023-02626-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00429-023-02626-x.pdfCitation Count: 4
-
OPENTitle: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesisJournal Name: Protein SciencePublisher: WileyVol: 32Issue #: 8Start Page: e4728End Page: e4728Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pro.4728Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10367600/pdf/PRO-32-e4728.pdfCitation Count: 2
-
OPENTitle: Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 1005Issue #:Start Page: 178031End Page: 178031Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2025.178031Best OA location URL: https://doi.org/10.1016/j.ejphar.2025.178031Citation Count: 0
-
OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 19
-
OPENTitle: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease PatientJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 4Start Page: 625End Page: 625Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells12040625Best OA location URL: https://www.mdpi.com/2073-4409/12/4/625/pdf?version=1676960152Citation Count: 48
-
OPENTitle: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 32Start Page: e2402206121End Page: e2402206121Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2402206121Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.2402206121Citation Count: 41
-
OPENTitle: Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissuesJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 1Start Page: 109End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41587-023-01751-6Best OA location URL: https://www.nature.com/articles/s41587-023-01751-6.pdfCitation Count: 59
-
OPENTitle: Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disordersJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 46Issue #: 5Start Page: 4397End Page: 4414Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11357-024-01120-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11357-024-01120-4.pdfCitation Count: 9
-
OPENTitle: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 17796End Page: 17796Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-45078-3Best OA location URL: https://www.nature.com/articles/s41598-023-45078-3.pdfCitation Count: 16
-
OPENTitle: Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesiaJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 6Start Page: 2246End Page: 2255Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10411-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11197155Citation Count: 15
-
OPENTitle: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) CellsJournal Name: BiomoleculesPublisher: MDPI AGVol: 14Issue #: 6Start Page: 647End Page: 647Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom14060647Best OA location URL: https://www.mdpi.com/2218-273X/14/6/647/pdf?version=1717136963Citation Count: 7
-
OPENTitle: MAPT Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified AnalysisJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 1Start Page: 46End Page: 46Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes15010046Best OA location URL: https://www.mdpi.com/2073-4425/15/1/46/pdf?version=1703728220Citation Count: 2
-
OPENTitle: An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 3Start Page: fcaf159End Page: fcaf159Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf159Best OA location URL: https://doi.org/10.1093/braincomms/fcaf159Citation Count: 0
-
OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page: 212End Page: 212Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03702-3Citation Count: 7
-
OPENTitle: Differences in the Presentation and Progression of Parkinson's Disease by SexJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 106End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28312Citation Count: 100
-
OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
-
OPENTitle: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cellsJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001Best OA location URL: https://doi.org/10.1016/j.nepig.2016.03.001Citation Count: 0
- VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A12024OPENTitle: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1Journal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202311189Best OA location URL: https://doi.org/10.1083/jcb.202311189Citation Count: 13
-
OPENTitle: Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremorJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 201Issue #:Start Page: 106691End Page: 106691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106691Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106691Citation Count: 1
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206Citation Count: 198
-
OPENTitle: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interactionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 72End Page: 76Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007Best OA location URL: https://zenodo.org/record/3421671Citation Count: 27
-
OPENTitle: Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers InitiativeJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 13Issue #:Start Page: 100385End Page: 100385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100385Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100385Citation Count: 0
- Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model2023OPENTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 12